Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter. Read more about Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter.
Growing pains for the environmental genetics of breast cancer: observations on a study of the glutathione S-transferases. Read more about Growing pains for the environmental genetics of breast cancer: observations on a study of the glutathione S-transferases.
Prediagnostic serum vitamin D and breast cancer. Read more about Prediagnostic serum vitamin D and breast cancer.
Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. Read more about Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies.
Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. Read more about Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer.
Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. Read more about Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
Serologic detection of human papillomavirus-related anogenital disease: new opportunities and challenges. Read more about Serologic detection of human papillomavirus-related anogenital disease: new opportunities and challenges.
Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. Read more about Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women.
Deficiencies in the analysis of breast cancer screening data. Read more about Deficiencies in the analysis of breast cancer screening data.
PR1--a monoclonal antibody that reacts with an antigen on the surface of normal and malignant prostate cells. Read more about PR1--a monoclonal antibody that reacts with an antigen on the surface of normal and malignant prostate cells.
